Choate Named 2015 “Patent Strategy and Management Team of the Year” by LMG Life Sciences

Choate announced today that the firm has been named the 2015 “Patent Strategy and Management Team of the Year” by LMG Life Sciences. The annual LMG Life Sciences awards recognize the leading attorneys, law firms and in-house counsel teams that have played a significant role in the life sciences industry over the last 12 months.  An awards ceremony was held on September 16, 2015 in New York City.

Choate’s Life Sciences Group is internationally recognized for its expertise in representing leading life sciences companies and institutions in all aspects of their business including IP protection, strategies, collaborations and licenses, technology transfer, financings, M&A transactions and general advice and counsel. The group is led by Dr. Brenda Herschbach Jarrell and Dr. Charles Lyon.  Dr. Jarrell was also named a 2015 “Patent Prosecution Attorney of the Year” finalist by LMG Life Sciences.  The award-winning team is comprised of nearly 40 IP attorneys, patent agents, and staff scientists – many with PhDs or other advanced degrees – who have significant industry experience in a wide range of biotech, pharmaceutical, and specialty chemical industries, including cutting edge areas such as small molecule therapeutics, biologics, vaccines, diagnostic technologies, and nanomedicines.  The firm’s life sciences transactional and licensing work spans the US, Canada, Europe, Asia, and the Middle East.    

The Legal Media Group publishes the LMG Life Sciences guide annually in association with Euromoney Institutional Investor.  The guide is based on nearly 1,000 interviews and surveys completed by partners active in the market, interviews with clients and leading lawyers, and a review of public information.